NEWSWIRETODAY Press Release& Newswire Distribution | HOME
PRTODAY / NewswireToday press release distribution service network
More news: Research
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award - Cutting-edge Organ-on-a-Chip Technology Enhances R&D Productivity and Improves Patient Safety -
Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award


NewswireTODAY - /newswire/ - San Antonio, TX, United States, 2023/10/12 - Cutting-edge Organ-on-a-Chip Technology Enhances R&D Productivity and Improves Patient Safety -

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Frost & Sullivan recently researched the North American Organ-on-a-Chip industry and, based on its findings, recognizes Emulate with the 2023 Technology Innovation Leadership Award for their successful development of Organ-on-a-Chip technology, which replicates the physiological processes and intricate intracellular networks of specific organs. The company is at the forefront of developing human-relevant Organ-Chip models, helping its customers to reduce and refine their dependence on animal models for preclinical studies.

Emulate Organ-Chip models are used by academia and the pharmaceutical industry across a wide variety of areas, including toxicology, immunology, gene therapy, and cancer research. Within academia, Emulate Organ-Chips enable researchers to develop new models with closer-to-human gene expression to better understand human physiology and disease mechanisms. Within the pharmaceutical industry, the technology is primarily used to help determine a drug candidate’s efficacy and toxicity ahead of clinical trials, helping to improve the quality of drugs that enter the clinic.

“Emulate’s customers include 24 of the top 25 pharma companies, and it has placed more than 430 instruments in labs worldwide, making it the most prominent company in the Organ-on-a-Chip platform industry,” said Neeraja Vettekudath, Best Practices Research Analyst at Frost & Sullivan. “Since the passing of the FDA Modernization Act in December 2022, Emulate has seen a 90% increase in instrument placements.”

Emulate has engineered multiple functional Organ-Chip models, including a Liver-Chip, Colon Intestine-Chip, Duodenum Intestine-Chip, and Proximal Tubule Kidney-Chip. They also offer a Basic Research Kit which can be used by researchers to build their own Organ-Chip models and applications, a culture module platform for mimicking human physiology, and software for interpreting the data. In an effort to showcase the scientific maturity of the technology, Emulate published a landmark study in Communication Medicine, part of Nature portfolio, demonstrating that the Emulate human Liver-Chip was able to correctly identify 87% of drugs that caused drug-induced liver injury in patients despite passing through animal testing. At the same time, the Liver-Chip did not falsely identify any drugs as toxic supporting its use in toxicology screening workflows. Had the Emulate human Liver-Chip been available when the drugs tested were being developed, 242 patient lives could have been saved.

“Emulate’s integration of microfluidics, bioengineering, and live cells helps create all the essential features of human biological systems. The company has successfully developed Organ-Chip models that can efficiently recreate the cellular microenvironment cells inside the human body to emulate human response, which cannot be done in animal models,” noted Vettekudath. For its strong overall performance, Emulate earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award in the North American Organ-on-a-Chip platform industry.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Emulate

Emulate ( is igniting a new era in human health with industry-leading Organ-on-a-Chip technology. The Human Emulation System provides a window into the inner workings of human biology and disease, offering researchers an innovative technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Pioneered at the Wyss Institute for Biologically Inspired Engineering at Harvard University and backed by Northpond Ventures, Founders Fund, and Perceptive Advisors, Organ-on-a-Chip technology assists researchers across academia, pharma, and government industries through its predictive power and ability to recreate true-to-life human biology.

Media Contact:
Michael Sullivan, Emulate, Inc.
E: msullivan[.]
P: 503-799-7520

Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick NewswireToday Visibility Checker


Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!

Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Emulate | Frost & Sullivan
Contact: Claudia Toscano - 
210-477-8417 claudia.toscano[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Research Most Recent Related Newswires:

BASF to Research on Alternatives to Animal Testing on Behalf of the European Chemicals Agency (ECHA)
NEC Joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3)
Tractebel to Conduct Feasibility Study for Iconic Einstein Telescope
Parexel Recognized with Frost & Sullivan’s 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions
ABB and Imperial College Extend Carbon Capture Collaboration to Support Future Workforce and Energy Transition
ANDRITZ Opens The Food Innovation Xperience Test Center
CEA and Siemens Collaborate on Research to Expand Applications of Digital Twin for Industry
Innovative Research for Malaria Control Driven by Three Collaborating Parties - Swiss TPH, BASF and Promega
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells
Thales Alenia Space Will be Part of the Consortium to Develop the Destination Earth Core Service Platform
Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine At ASCO 2023
State of Indiana, Purdue University and Imec Announce MOU on Research and Development Partnership Powering State’s Semiconductor Ecosystem Growth
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for its Competitive Strategies
Siemens and Centrale Nantes to Continue Cutting-edge Simulation Research
Thales and Marvel Fusion Cooperate with ELI-NP

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  Limelon Advertising, Co.

  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (